NO872729D0 - Cefalosporinhydrat og fremgangsmaate for dets fremstilling. - Google Patents

Cefalosporinhydrat og fremgangsmaate for dets fremstilling.

Info

Publication number
NO872729D0
NO872729D0 NO872729A NO872729A NO872729D0 NO 872729 D0 NO872729 D0 NO 872729D0 NO 872729 A NO872729 A NO 872729A NO 872729 A NO872729 A NO 872729A NO 872729 D0 NO872729 D0 NO 872729D0
Authority
NO
Norway
Prior art keywords
cephalosporinhydrate
procedure
preparation
Prior art date
Application number
NO872729A
Other languages
English (en)
Other versions
NO872729L (no
NO170889B (no
NO170889C (no
Inventor
Yoshio Hamashima
Kyoji Minami
Kyozo Kawata
Teruo Sakamoto
Toyohiko Takeda
Yusuke Suzuki
Masanori Tujikawa
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61156954A external-priority patent/JP2544113B2/ja
Priority claimed from JP21626086A external-priority patent/JPH0717651B2/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO872729D0 publication Critical patent/NO872729D0/no
Publication of NO872729L publication Critical patent/NO872729L/no
Priority to NO911964A priority Critical patent/NO303264B1/no
Priority to NO921401A priority patent/NO921401D0/no
Publication of NO170889B publication Critical patent/NO170889B/no
Publication of NO170889C publication Critical patent/NO170889C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
NO872729A 1986-07-02 1987-06-30 Fremgangsmaate for fremstilling av et stabilt krystallinskdi- eller trihydrat av 7beta-((z)-2-(2-aminotiazol-4-yl)-4-karboksybut-2-enoylamino)-3-cefem-4-karboksylsyre NO170889C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO911964A NO303264B1 (no) 1986-07-02 1991-05-22 FremgangsmÕte for fremstilling av et stabilt kapselpreparat
NO921401A NO921401D0 (no) 1986-07-02 1992-04-09 Fremgansmaate for fremstilling av et stabilt kapselpreparat

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61156954A JP2544113B2 (ja) 1986-07-02 1986-07-02 安定なカプセル製剤
JP21626086A JPH0717651B2 (ja) 1986-09-12 1986-09-12 経口投与用セフアロスポリン水和物結晶

Publications (4)

Publication Number Publication Date
NO872729D0 true NO872729D0 (no) 1987-06-30
NO872729L NO872729L (no) 1988-01-04
NO170889B NO170889B (no) 1992-09-14
NO170889C NO170889C (no) 1992-12-23

Family

ID=26484565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872729A NO170889C (no) 1986-07-02 1987-06-30 Fremgangsmaate for fremstilling av et stabilt krystallinskdi- eller trihydrat av 7beta-((z)-2-(2-aminotiazol-4-yl)-4-karboksybut-2-enoylamino)-3-cefem-4-karboksylsyre

Country Status (27)

Country Link
US (2) US4812561A (no)
KR (1) KR950005302B1 (no)
CN (1) CN1015106B (no)
AR (1) AR243893A1 (no)
AT (1) AT392472B (no)
AU (1) AU594167B2 (no)
BE (1) BE1001691A4 (no)
CA (1) CA1283405C (no)
CH (1) CH672788A5 (no)
DE (1) DE3721913A1 (no)
DK (1) DK161080C (no)
ES (2) ES2004952A6 (no)
FI (1) FI89052C (no)
FR (1) FR2601014B1 (no)
GB (1) GB2192183B (no)
GR (1) GR871014B (no)
HK (1) HK47893A (no)
HU (1) HU200777B (no)
IE (1) IE59613B1 (no)
IL (1) IL83059A (no)
IT (1) IT1211469B (no)
NL (1) NL193136C (no)
NO (1) NO170889C (no)
NZ (1) NZ220764A (no)
PL (1) PL159180B1 (no)
RU (1) RU1829932C (no)
SE (1) SE466257B (no)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5599557A (en) * 1992-04-30 1997-02-04 Schering Corporation Stable hydrated cephalosporin dry powder for oral suspension formulation
EP1860127B1 (en) * 1998-10-27 2011-01-12 Westlake Longview Corporation Process for the polymerization of olefins; polyethylenes, and films and articles produced therefrom
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
US8425936B2 (en) * 2003-07-21 2013-04-23 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
AU2004264939A1 (en) * 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
US20050142187A1 (en) * 2003-12-24 2005-06-30 Treacy Donald J.Jr. Enhanced absorption of modified release dosage forms
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20110104109A1 (en) * 2005-07-13 2011-05-05 Frank Bennett Tetracyclic indole derivatives and their use for treating or preventing viral infections
WO2007054550A1 (en) 2005-11-11 2007-05-18 Boehringer Ingelheim International Gmbh Quinazoline derivatives for the treatment of cancer diseases
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
US8546420B2 (en) * 2006-12-22 2013-10-01 Merck Sharp & Dohme Corp. 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
RU2009127855A (ru) 2006-12-22 2011-01-27 Шеринг Корпорейшн (US) 4,5 циклоаннелированные производные индола для лечения или предотвращения вируса гепатита с (hcv) и родственных вирусных инфекций
EP2081922B1 (en) 2006-12-22 2012-02-01 Schering Corporation 5,6-Ring annulated indole derivatives and use thereof
RU2010111550A (ru) * 2007-08-29 2011-10-10 Шеринг Корпорейшн (US) 2,3-замещенные индольные производные для лечения вирусных инфекций
EP2408761B1 (en) * 2007-08-29 2014-01-01 Merck Sharp & Dohme Corp. Substituted indole derivatives and methods of use thereof
AU2008295485B2 (en) * 2007-08-29 2013-09-05 Merck Sharp & Dohme Corp. 2,3-substituted azaindole derivatives for treating viral infections
CA2705587A1 (en) * 2007-11-16 2009-05-22 Schering Corporation 3-aminosulfonyl substituted indole derivatives and methods of use thereof
CN102099351A (zh) * 2007-11-16 2011-06-15 先灵公司 3-杂环取代的吲哚衍生物及其使用方法
EP2303893B1 (en) * 2008-06-13 2016-12-07 Merck Sharp & Dohme Corp. Tricyclic indole derivatives
AR072938A1 (es) 2008-08-20 2010-09-29 Southern Res Inst Derivados de piridina y pirimidina azosustituidos y su uso en el tratamiento de infecciones virales
AR072937A1 (es) 2008-08-20 2010-09-29 Schering Corp Derivados de piridina y pirimidina sustituida y su uso en el tratamiento de infecciones virales
AU2009282574B2 (en) 2008-08-20 2014-08-21 Merck Sharp & Dohme Corp. Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
TW201020245A (en) 2008-08-20 2010-06-01 Schering Corp Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
JP2012528195A (ja) 2009-05-29 2012-11-12 メルク・シャープ・アンド・ドーム・コーポレーション Ｃ型肝炎などの疾患を処置するための３つの結合アリール部分で構成された抗菌性化合物
SI2451445T1 (sl) 2009-07-06 2019-07-31 Boehringer Ingelheim International Gmbh Postopek za sušenje BIBW2992, njegovih soli in trdnih farmacevtskih formulacij, ki obsegajo to aktivno sestavino
WO2011066241A1 (en) 2009-11-25 2011-06-03 Schering Corporation Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
WO2011087740A1 (en) 2009-12-22 2011-07-21 Schering Corporation Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
EP2536410B1 (en) 2010-02-18 2015-09-23 Merck Sharp & Dohme Corp. Substituted pyrimidine derivatives and their use in treating viral infections
ES2558554T3 (es) 2010-03-09 2016-02-05 Merck Sharp & Dohme Corp. Compuestos de sililo tricíclicos condensados y métodos de uso de los mismos para el tratamiento de enfermedades víricas
EP2566449B1 (en) 2010-05-04 2014-10-08 Mahmut Bilgic Pharmaceutical compositions comprising ceftibuten
EP2598149A4 (en) 2010-07-26 2014-09-10 Merck Sharp & Dohme SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES
US9254292B2 (en) 2010-09-29 2016-02-09 Merck Sharp & Dohme Corp. Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
EP2696681B1 (en) 2011-04-13 2018-10-03 Merck Sharp & Dohme Corp. 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
US9156872B2 (en) 2011-04-13 2015-10-13 Merck Sharp & Dohme Corp. 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2013033901A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
WO2013033899A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
WO2013033900A1 (en) 2011-09-08 2013-03-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
WO2013039876A1 (en) 2011-09-14 2013-03-21 Merck Sharp & Dohme Corp. Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
EP2833874A1 (en) * 2012-04-04 2015-02-11 Mahmut Bilgic Capsule formulations comprising ceftibuten
EP2815743A1 (en) 2013-06-21 2014-12-24 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten formulations
US10167298B2 (en) 2013-10-30 2019-01-01 Merck Sharp & Dohme Corp. Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
US9242965B2 (en) 2013-12-31 2016-01-26 Boehringer Ingelheim International Gmbh Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
CN103948932B (zh) * 2014-04-17 2016-03-16 海南日中天制药有限公司 一种头孢克肟组合物及其制备方法
EP3031450A1 (en) 2014-12-12 2016-06-15 Sanovel Ilac Sanayi ve Ticaret A.S. Ceftibuten capsule compositions
AU2017261828B2 (en) 2016-05-13 2023-04-13 Aeromics, Inc. Crystals
CN106397454B (zh) * 2016-08-30 2018-08-24 山东罗欣药业集团股份有限公司 一种抗感染药物头孢布烯晶型化合物及其组合物
CN106397455B (zh) * 2016-08-30 2018-08-31 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢布烯晶体化合物及其组合物
CN106397457A (zh) * 2016-09-21 2017-02-15 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432270A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
CN106432271A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢布烯晶体化合物
CN106432272A (zh) * 2016-09-21 2017-02-22 临沂草之美医药科技有限公司 一种制备治疗外科手术感染的药物头孢布烯晶体化合物的方法
EP4362950A1 (en) * 2021-07-01 2024-05-08 Qpex Biopharma, Inc. Crystalline forms of ceftibuten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
JPS5726692A (en) * 1980-07-22 1982-02-12 Fujisawa Pharmaceut Co Ltd Preparation of stable crystal of salt of ceftizoxime
DE3037997A1 (de) * 1980-10-08 1982-05-13 Bayer Ag (beta) -lactamantibiotika, verfahren zu deren herstellung sowie sie enthaltende mittel
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
AU575854B2 (en) * 1983-10-04 1988-08-11 Shionogi & Co., Ltd. 7beta-(carboxyalkenamido) cephalosporins
AU580855B2 (en) * 1985-03-29 1989-02-02 Shionogi & Co., Ltd. Alkeneamidocephalosporin esters

Also Published As

Publication number Publication date
IL83059A (en) 1992-03-29
CH672788A5 (no) 1989-12-29
NZ220764A (en) 1989-09-27
IE871738L (en) 1988-01-02
PL159180B1 (pl) 1992-11-30
SE8702705L (sv) 1988-01-03
HU200777B (en) 1990-08-28
IE59613B1 (en) 1994-03-09
BE1001691A4 (fr) 1990-02-13
FI872903A (fi) 1988-01-03
NO872729L (no) 1988-01-04
US4812561A (en) 1989-03-14
ATA165887A (de) 1990-09-15
KR950005302B1 (ko) 1995-05-23
DK161080C (da) 1991-11-11
KR880001670A (ko) 1988-04-26
FI89052B (fi) 1993-04-30
GB8715064D0 (en) 1987-08-05
FI89052C (fi) 1993-08-10
NL8701507A (nl) 1988-02-01
HK47893A (en) 1993-05-27
AT392472B (de) 1991-04-10
CN1015106B (zh) 1991-12-18
DK161080B (da) 1991-05-27
AR243893A1 (es) 1993-09-30
GR871014B (en) 1987-11-02
DE3721913A1 (de) 1988-01-07
FR2601014B1 (fr) 1990-09-14
DK336487D0 (da) 1987-06-30
AU7504087A (en) 1988-01-07
PL266567A1 (en) 1988-07-21
NL193136B (nl) 1998-08-03
IL83059A0 (en) 1987-12-31
NL193136C (nl) 1998-12-04
FI872903A0 (fi) 1987-07-01
CA1283405C (en) 1991-04-23
SE466257B (sv) 1992-01-20
NO170889B (no) 1992-09-14
NO170889C (no) 1992-12-23
FR2601014A1 (fr) 1988-01-08
SE8702705D0 (sv) 1987-06-30
IT8767566A0 (it) 1987-07-01
IT1211469B (it) 1989-11-03
ES2004952A6 (es) 1989-02-16
US4933443A (en) 1990-06-12
RU1829932C (ru) 1993-07-23
HUT44257A (en) 1988-02-29
DK336487A (da) 1988-01-03
CN87105009A (zh) 1988-03-23
GB2192183B (en) 1990-05-16
ES2008759A6 (es) 1989-08-01
AU594167B2 (en) 1990-03-01
GB2192183A (en) 1988-01-06

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
NO882356L (no) Naeringsmiddel og fremgangsmaate for dets fremstilling.
DK550386D0 (da) Engangsble og fremgangsmaade til fremstilling deraf.
NO873402D0 (no) Dyreforprodukt og fremgangsmaate for dets fremstilling.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO880434L (no) Bedoevelsesmiddel og fremgangsmaate for bruk derav.
NO893748L (no) Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling.
DK185187D0 (da) Lokkemad til snegle, dets fremstilling og anvendelse
NO880186D0 (no) Tetrapeptidinhibitor samt fremgangsmaate for dets fremstilling og anvendelse derav.
DK315387A (da) Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
NO864194L (no) Slipekorn og fremgangsmaate til fremstilling derav.
DK50387A (da) Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling
NO883399L (no) Angioplastisk kateter og fremgangsmaate for dets bruk.
DK525687D0 (da) Enzymholdigt praeparat, dets fremstilling og anvendelse
NO165421C (no) Fremgangsmaate og anordning for avskinning.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
DK296687A (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
IT8621632A0 (it) Bromofluroetilipofluorito eprocedimento per la sua preparazione.
DK125087A (da) Efomycin g., dets fremstilling og anvendelse
NO873045L (no) Fremgangsmaate og system for dehydrering.
NO870299D0 (no) Liposom/antrakinon-legemiddelpreparat og fremgangsmaate for dets fremstilling.
NO873481D0 (no) Peptidpreparat, fremgangsmaate for dets fremstilling og anvendelse derav.
IT1222637B (it) Procedimento per preparare l-triptofano e dl-serina
NO165243C (no) Hoeysvovelholdige tioetere og fremgangsmaate til fremstilling derav.

Legal Events

Date Code Title Description
MK1K Patent expired